ImageneBio, Inc.
IMA· Nasdaq
Released Aug 5, 2026, before the open
10-Q filed Aug 5, 2026, 36 days after period end · 0001193125-26-333920
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | — | $0.00 | — | $2.00M |
| Net Income | -$10.18M | -$7.59M | -$6.26M | -$17.12M |
| EPS Diluted |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$0.63 |
| -$4.46 |
| -$0.28 |
| -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.